COMPARISON OF THREE DIFFERENT PRIMING REGIMENS BASED ON IDARUBICIN, ACLACINOMYCIN OR PIRARUBICIN FOR REFRACTORY/RELAPSE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Kourong Miao, 99772

HISTOLOGICAL DISTRIBUTION, TREATMENT AND PROGNOSIS OF PERIPHERAL T-CELL LYMPHOMAS: AN ANALYSIS OF 505 PATIENTS IN TAIWAN

EHA Library, Hsiao-Wen Kao, 99773

LONG-TERM RESULTS OF TREATMENT OF DIFFUSE LARGE CELL LYMPHOMA ASSOCIATED WITH HEPATITIS C (DLBCL+C).

EHA Library, sergey lepkov, 99774

INTERIM 18F-FGD PET/CT MAY NOT PREDICT THE OUTCOME IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS TREATED WITH INTENSIVE METHOTREXATE AND CYTARABINE

EHA Library, Jae-Cheol Jo, 99775

APPLICATION OF SYSTEMS PHARMACOLOGY MODELING FOR EVALUATION OF THERAPIES EFFECT ON BLAST DYNAMICS IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Antonina Nikitich, 99776

C-MYC AND BCL2 TRANSLOCATION FREQUENCY IN DIFFUSE LARGE B CELL LYMPHOMAS

EHA Library, Bahar Akkaya, 99777

THE D816V C-KIT MUTATION HAS HIGHER ABILITY OF JAK-STAT AND SRC FAMILY KINASE THAN N822K C-KIT MUTATION, AND THEREFORE PROLIFERATION ACTIVITY IS HIGH IN CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA.

EHA Library, Ikuko Omori, 99778

FREQUENCY AND PROGNOSTIC RELEVANCE OF HTERT SPLICED VARIANTS IN AML.

EHA Library, Paolo Bernasconi, 99779

COMPLEMENTARY DYNAMIC BH3 PROFILES PREDICT INDUCTION OF APOPTOSIS BY THE MULTI-KINASE INHIBITOR TG02 IN COMBINATION WITH THE BH3 MIMETIC ABT-199 IN AML CELLS

EHA Library, Monica Pallis, 99780

LONG-TERM OUTCOME OF ADULTS WITH FIRST-RELAPSED OR REFRACTORYSYSTEMIC ALCL: A LYSA STUDY

EHA Library, Alexandre Morel, 99781

THE SYK INHIBITORS R788, R406 AND P505-15 COUNTERACT NEOPLASTIC CELL SURVIVAL AND SYNERGIZE WITH MIDOSTAURIN IN PRODUCING GROWTH ARREST IN AML CELL LINES AND PRIMARY AML BLASTS

EHA Library, René Gaupmann, 99782

NEXT GENERATION SEQUENCING OF MYELOID MALIGNANCIES IDENTIFIED A SPECTRUM OF NOVEL MUTATIONS IN EPIGENETIC REGULATORS – CENTER FOR INDIVIDUALIZED MEDICINE CLINIC EXPERIENCE.

EHA Library, Moussab Damlaj, 99784

A COMPREHENSIVE ANALYSIS OF ACCESSIBLE BONE MARROW PROTEINS FOR ANTIBODY-BASED THERAPY OF ACUTE MYELOID LEUKEMIA

EHA Library, Linus Angenendt, 99785

GASTROINTESTINAL TRACT POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) AFTER KIDNEY TRANSPLANT: A 17-YEAR BRAZILIAN SINGLE-CENTRE EXPERIENCE

EHA Library, Egyla Cavalcante, 99786

THE ROLE OF UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HIGH-RISK PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Hyunsoo Cho, 99787

FAVORABLE OUTCOME IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA IN A SINGLE CENTRE: THE PADUA EXPERIENCE.

EHA Library, Silvia Imbergamo, 99788

TARGETED NEXT GENERATION SEQUENCING (NGS) IN PARALLEL ANALYSES OF CHILDHOOD (CAML) AND ADULT ACUTE MYELOID LEUKEMIA (AAML) PATIENTS

EHA Library, Irena Glumac, 99789

CD30 EXPRESSION IN DLBCL, INCIDENCE AND PROGNOSIS VALUE: A SINGLE-INSTITUTION EXPERIENCE.

EHA Library, Laura García-Sanchis, 99790

VSTM-V1 IS A POTENTIAL MYELOID DIFFERENTIATION ANTIGEN GENE THAT IS DOWNREGULATED IN BONE MARROW CELLS FROM PATIENTS WITH MYELOID LEUKEMIA

EHA Library, Jiao Zhou, 99791

IDENTIFICATION OF CYTOGENETIC AND MOLECULAR SUBGROUPS OF ACUTE MYELOID LEUKEMIAS SHOWING L-ASPARAGINASE IN VITRO SENSITIVITY

EHA Library, Salvatore Nicola Bertuccio, 99792

AZACITIDINE FOR THE TREATMENT OF MDS, AML AND CMML: THE SOUTH WALES (UK) EXPERIENCE

EHA Library, Ali Mahdi, 99793

MIRNA SIGNATURES ASSOCIATED WITH MOLECULAR MARKERS IN ACUTE MYELOID LEUKEMIA

EHA Library, Marta Llop, 99794

PREGNANCY MANAGEMENT IN VON WILLEBRAND'S DISEASE

EHA Library, Maria Vinogradova, 99795

EFFICACY AND SAFETY PROFILE OF RIVAROXABAN FOLLOWING HIP AND KNEE ARTHROPLASTY

EHA Library, Sheena Patel, 99796

ANALYSIS OF GENETIC POLYMORPHISMS IN DNA REPAIR GENES IN ASSOCIATION WITH ACUTE MYELOID LEUKEMIA AND ITS SPECIFIC CHROMOSOMAL ABNORMALITIES

EHA Library, Aggeliki Daraki, 99797

FAVORABLE PROGNOSTIC IMPACT OF NMP1 MUTATION IN ELDERLY PATIENTS WITH NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA

EHA Library, Marijana Virijevic, 99798

LONG TERM EFFICACY OF CONSOLIDATION TREATMENT WITH COURSES OF HIGH-DOSE CYTARABINE AND LIMITED AUTOLOGOUS PBSC SUPPORT IN A SERIES OF ADULTS WITH ACUTE MYELOID LEUKEMIA NOT AT HIGH BIOLOGICAL RISK

EHA Library, Erika Borlenghi, 99799

HIGH CURE RATE OF YOUNGER AML PATIENTS WITH FLUDARABINE, CYTARABINE AND IDARUBICINE INDUCTION AND RISK ORIENTED CONSOLIDATION: TEN- YEARS REAL LIFE EXPERIENCE

EHA Library, Paola Minetto, 99800

VITAMIN D LEVELS OF CHILDREN WITH FANCONI ANEMIA

EHA Library, Canan Albayrak, 99801

CLOFARABINE AND HIGH-DOSE CYTARABINE ARABINOSIDE (CLARA) FOR PRIMARY REFRACTORY OR RELAPSED ACUTE MYELOID LEUKAEMIA – A PROSPECTIVE FOLLOW-UP STUDY OF 60 PATIENTS

EHA Library, Harinder Gill, 99802

DISTINCT EPIDEMIOLOGIC EXPOSURES AND PROGNOSTIC FACTORS FOR SURVIVAL IN OLDER ADULTS AGE ≥70 YEARS RECEIVING LOW INTENSITY THERAPY FOR ACUTE MYELOID LEUKEMIA (AML)

EHA Library, James M Foran, 99803

IDENTIFICATION OF PROGNOSTIC FACTORS RELATED TO THERAPEUTIC OUTCOMES OF CHEMOTHERAPY AND ALLOGENEIC STEM CELL TRANSPLANTATION IN 120 ACUTE MYELOID LEUKEMIA PATIENTS WITH MONOSOMAL KARYOTYPE IN KOREA

EHA Library, Hyunsoo Cho, 99804

NO INCREASE IN LEVEL OF FATIGUE AMONG LONG-TERM SURVIVORS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Åsa Derolf, 99805

CORE-BINDING FACTOR IN CHILDHOOD ACUTE MYELOID LEUKEMIA

EHA Library, Olfa Kassar, 99806

PROGNOSATIC RISK SCORE FOR HAEMORRHAGIC EARLY DEATH IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Mirjana Mitrovic, 99807

THERAPY-RELATED ACUTE MYELOID LEUKEMIA IN ADULTS: IS AGE YOUNGER THAN 40 CLINICALLY RELEVANT?

EHA Library, Deniz Peker, 99808

COMBINATION OF CLOFARABINE AND CYTARABINE IN THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA

EHA Library, Branimir Spassov, 99809

CCAAT/ENHANCER BINDING PROTEIN ALPHA (CEBPA) NEW MUTATIONS IDENTIFIED BY THE HEMATOLOGY OF FLORENCE

EHA Library, Vanessa Ponziani, 99810

REGULATION OF CD38 BY IRF4 IN CHRONIC LYMPHOCYTIC LEUKAEMIA

EHA Library, Helen Marr, 99811

13Q DELETION IS PREDOMINANT CYTOGENETIC ABERRATION NEWLY AQUIRED DURING CHRONIC LYMPHOCYTIC LEUKEMIA COURSE IRRESPECTIVE OF DISEASE ACTIVITY AND TREATMENT STATUS

EHA Library, Jana Kotaskova, 99812

NOVEL NO-ASA DERIVATIVES ARE NEW PROMISING AGENTS IN THE THERAPY OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND SOLID CANCERS

EHA Library, Hanna Flamme, 99813

A RETROSPECTIVE CASE CONTROL STUDY ASSOCIATING CHRONIC LYMPHOCYTIC LEUKEMIA AND ITS SPECIFIC ABERRATIONS WITH CERTAIN RISK FACTORS

EHA Library, Kalliopi Manola, 99814

CLINICAL COURSE OF LEPTOMENINGEAL INVOLVEMENT OF ACUTE MYELOID LEUKEMIA : 14-YEARS SINGLE CENTER EXPERIENCE

EHA Library, Ji Hyun Kwon, 99815

NEW PROGNOSTIC MARKER IN CHRONIC LYMPHOCYTIC LEUKEMIA: PLASMA CCL3 (MIP-1Α)

EHA Library, Ayse Salihoglu, 99816

OVERALL SURVIVAL (OS) AND CLINICAL OUTCOMES IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH AZACITIDINE (AZA) OR LOW-DOSE CYTARABINE (LDAC) IN THE AZA-AML-001 STUDY

EHA Library, John F.Seymour, 99817

CHARACTERIZATION OF NORMAL AND PATHOLOGICAL LYMPHOID POPULATIONS: VALIDATION OF A 10-COLORS FLOW CYTOMETRY PROTOCOL FOR ROUTINE DIAGNOSIS

EHA Library, Lauren Rigollet, 99818

CHEMOTHERAPY EXPOSURE AND SURVIVAL AMONG PATIENTS DIAGNOSED WITH CHRONIC LYMPHOID LEUKEMIA

EHA Library, Patience Musingarimi, 99819

REAL-WORLD OUTCOMES OF PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION

EHA Library, Nicole Lamanna, 99820

MODELING THE EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND WALDENSTROM'S MACROGLOBULINEMIA (WM) IN FRANCE

EHA Library, Xavier Troussard, 99822

CLINICAL FEATURES AND OUTCOMES OF HYPOCELLULAR ACUTE MYELOID LEUKEMIA IN ADULTS: KOREAN AML REGISTRY DATA

EHA Library, Ik-Chan SONG, 99823

REDUCED-INTENSITY TRANSPLANTATION AS A PART OF STANDARD TREATMENT STRATEGY IN PATIENTS AGED 60 TO 70 YEARS WITH ACUTE MYELOID LEUKEMIA – SINGLE CENTRE EXPERIENCE.

EHA Library, Michal Karas, 99824

THE OCCURRENCE OF OTHER MALIGNANCIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Milena TodorovicBalint, 99825

THE DNMT3A R882 MUTATION WITH FLT3-ITD POSITIVITY IS AN EXTREMELY POOR PROGNOSTIC FACTOR IN PATIENTS WITH NORMAL KARYOTYPE AML AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Hyeoung-Joon Kim, 99826

RETROSPECTIVE EVALUATION OF 83 PATIENTS WITH HAIRY CELL LEUKEMIA TREATED WITH 3 DIFFERENT TREATMENT MODALITIES IN THE LAST TWO DECADES: A SINGLE CENTER EXPERIENCE

EHA Library, Seniz Ongoren Aydin, 99827

DETECTION OF BCR-ABL GENE MUTATIONS IN CHRONIC MYELOID LEUKEMIA USING SENSITIVE LOW-DENSITY MICROARRAY APPROACH

EHA Library, Tatiana Nasedkina, 99828

SERUM CHEMOKINES AND CYTOKINES IN CLL PATIENTS TREATED WITH DUVELISIB, AN ORAL DUAL INHIBITOR OF PI3K-DELTA,GAMMA

EHA Library, Mark Douglas, 99829

CD26 ANTIGEN IS SPECIFIC FOR LEUKEMIC STEM CELLS IN CHRONIC MYELOID LEUKEMIA AND DISTINGUISHES PATIENT GROUPS WITH DIFFERENT RATIOS OF LEUKEMIC AND HEALTHY STEM CELLS

EHA Library, Martin Culen, 99830

MICROVESICLES IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Giovanni D'Arena, 99831

CHANGES IN LYMPHOCYTE SUBSETS, ANGIOGENIC FACTORS AND PLASMA CYTOKINES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA DURING TREATMENT WITH OFATUMUMAB AND LENALIDOMIDE

EHA Library, Candida Vitale, 99832

THE ROLE OF MICRORNAS IN RESPONSE TO NEW TARGETED THERAPIES IN CHRONIC MYELOID LEUKEMIA

EHA Library, Ana Bela Sarmento, 99833

QUANTITATIVE AND QUALITATIVE ANALYSIS OF REGULATORY T CELLS (TREGS) IN B CELL CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)

EHA Library, Vasiliki Pappa, 99834

FCGAMMARIIB HOMMOAGREGATION CAN INDUCE A PROSURVIVAL STATE IN CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS

EHA Library, Rosa Bosch, 99835

CHRONIC LYMPHOCYTIC LEUKEMIA CELLS ARE HIGHLY SUSCEPTIBLE TO DIRECT INHIBITION OF CHECKPOINT KINASE 1

EHA Library, Jana Zemanova, 99836

TYROSINE KINASE INHIBITOR THERAPY INDUCES ALTERATIONS OF CD137 AND CD137L EXPRESSION IN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Paulo Rodrigues-Santos, 99837

METABOLIC CHARACTERISTICS OF IMATINIB RESISTANT CHRONIC MYELOID LEUKEMIA WITH T315I MUTATION

EHA Library, Jun Young Heo, 99838

DISCOVERING ALTERNATIVE TARGETS IN CHRONIC MYELOID LEUKEMIA (CML): DETERMINATION OF EXPRESSION LEVELS OF BIOACTIVE SPHINGOLIPID GENES IN NEWLY DIAGNOSED AND DRUG-RESISTANT CML PATIENTS

EHA Library, Melis Kartal Yandim, 99839

COMPARISON OF TYROSINE-KINASE INHIBITORS AS FIRST-LINE TREATMENT FOR CHRONIC MYELOID LEUKEMIA: RESULTS OF A NETWORK META-ANALYSIS INCLUDING 6314 PATIENTS

EHA Library, Nicole Skoetz, 99840

IMMUNOPHENOTYPE OF CLL CASES WITH STEREOTYPED BCR IS CHARACTERIZED BY DECREASED CD23 EXPRESSION

EHA Library, Vladimir Strugov, 99841

FREQUENCY OF CLL-LIKE MONOCLONAL B LYMPHOCYTOSIS IN JAPANESE PEOPLE LIVING IN SAO PAULO, BRAZIL

EHA Library, Mariane Ferreirade, 99842

EVALUATION OF A QUANTITATIVE MULTIPLEX BCR-ABL1 ASSAY ALIGNED DIRECTLY TO THE WHO PRIMARY STANDARD REFERENCE MATERIALS TO REPORT EXPRESSION ON THE INTERNATIONAL SCALE

EHA Library, Justin Brown, 99843

OUTCOMES OF ANTICOAGULANT OR ANTIPLATELET USE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OR INDOLENT NON-HODGKIN’S LYMPHOMA IN IDELALISIB TRIALS

EHA Library, Peter Hillmen, 99844

ESTIMATED GLOMERULAR FILTRATION RATES OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS (TKIS) IN DASATINIB TRIALS: DASISION (CA180-056), CA180-034, AND CA180-035

EHA Library, Jorge Cortes, 99845

EFFICACY OF NILOTINIB VS HIGH-DOSE IMATINIB VS SUSTAINING STANDARD-DOSE IMATINIB IN EARLY CHRONIC PHASE CML PATIENTS WHO HAVE SUBOPTIMAL MOLECULAR RESPONSE TO FRONTLINE IMATINIB

EHA Library, Soo Young Choi, 99847

MINIMAL RESIDUAL DISEASE IN HAIRY CELL LEUKEMIA: DOES IT MATTER?

EHA Library, Abel Santos Carreira, 99848

LONG-TERM BOSUTINIB FOR PHILADELPHIA CHROMOSOME–POSITIVE (PH+) ADVANCED CHRONIC MYELOID LEUKEMIA (CML) AFTER PRIOR TYROSINE KINASE INHIBITOR FAILURE

EHA Library, Carlo Gambacorti-Passerini, 99849

TWO DECADES OF SINGLE-CENTER EXPERIENCE REGARDING THE TREATMENT, PREDICTORS OF SURVIVAL AND CAUSES OF DEATH IN PATIENTS WITH HAIRY CELL LEUKEMIA

EHA Library, Danijela Lekovic, 99850

EVALUATION OF A CENTRALIZED MOLECULAR MONITORING OF CHRONIC MYELOID LEUKEMIA THERAPY IN SOUTH KOREA

EHA Library, Soo Young Choi, 99851

COMPARATIVE ANALYSIS OF BCR-ABL AND VEGFR2 INHIBITORY ACTIVITIES OF PONATINIB, AXITINIB, AND PF-114

EHA Library, Joseph M Gozgit, 99852

MULTICENTER STUDY OF COMORBIDITY IN CANARIAN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH TYROSINE KINASE INHIBITORS

EHA Library, Maria Saez-Perdomo, 99853

THE RATE OF BCR-ABL DECLINE AS AN OPTIMIZED PREDICTOR OF OUTCOME FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE ON TREATMENT WITH TYROSINE KINASE INHIBITORS

EHA Library, Aleksandr Fomin, 99854

A STUDY OF CELL CYCLE KINETICS AND OF KU80 EXPRESSION AS A MARKER OF GENETIC INSTABILITY IN BONE MARROW MESENCHYMAL STEM CELLS OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Vasiliki Papadopoulou, 99855

BCR-ABL EXPRESSION IS REDUCED IN THE PRIMITIVE PRECURSOR FRACTION FROM CML TKI-TREATED PATIENTS.

EHA Library, Maria Sol Ruiz, 99856

EFFICACY AND SAFETY FOR DASATINIB IN EARLY CHRONIC PHASE CML PATIENTS WITH LATE SUBOPTIMAL RESPONSE TO FRONTLINE IMATINIB. PRELIMINARY RESULTS FROM DASAPOST STUDY

EHA Library, Valentin Garcia-Gutierrez, 99857

SELECTION OF RUNX1-MUTATED CLONE ASSOCIATED WITH RELAPSE AND BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA PATIENT AFTER ALLO-HSCT AS REVEALED BY TARGETED ENRICHMENT AND DEEP SEQUENCING

EHA Library, Iwona Solarska, 99858

NANOPORE SEQUENCING TO RAPIDLY CHARACTERISE LEUKEMIA-SPECIFIC GENOMIC TRANSLOCATION BREAKPOINTS

EHA Library, Andrew Chase, 99859

MISSPLICED GSK3Β TRANSCRIPT IS UNIVERSALLY EXPRESSED AND CANNOT BE USED TO PREDICT BLAST CRISIS TRANSFORMATION IN CHRONIC MYELOID LEUKAEMIA

EHA Library, Lihui Wang, 99860

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: REVIEW OF 28 CASES

EHA Library, Lucia Guerrero Fernandez, 99861

PREDICTIVE FACTORS FOR TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH IMATINIB-TREATED, UNDETECTABLE MOLECULAR RESIDUAL DISEASE: RESULTS FROM THE KID STUDY

EHA Library, Sung-Eun Lee, 99862

ASSESSING RISK FACTORS OF ELECTRONICALLY MEASURED MEDICATION NON-ADHERENCE IN CML PATIENTS: AN OBSERVATIONAL LONGITUDINAL DESIGN– A SUBANALYSIS OF THE TAKE-IT STUDY

EHA Library, Avi Leader, 99863

A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS

EHA Library, Michele Baccarani, 99864

IDENTIFICATION OF PREDICTIVE MARKERS OF IMMUNO-SENESCENCE WITH FOCUS ON TUMOR SUPPRESSIVE GENES: HEALTHY DONORS VERSUS PATIENTS DIAGNOSED WITH A LYMPHOPROLIFERATIVE DISEASE

EHA Library, Dominique BRON, 99865

CHRONIC EXPOSURE TO INTERFERON-ALPHA DRIVES MEDULLAR LYMPHOPOIESIS TOWARDS T CELL DIFFERENTIATION IN MICE

EHA Library, Marianna Di Scala, 99866

IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE: CURRENT INCIDENCE OF CYTOGENETIC REMISSION AND A VERY LONG-TERM AN INTENTION-TO-TREAT ANALYSIS

EHA Library, Oleg Shukhov, 99868

CORD BLOOD STEM CELLS BUT NOT ADULT STEM CELLS AFTER TRANSPLANTATION OVEREXPRESS STEMNESS AND REPROGRAMMING GENES PARTIALLY OVERLAPPING THE SIGNATURE OF INDUCED PLURIPOTENT STEM CELLS (IPS)

EHA Library, Daniela Cilloni, 99869

STROMAL CELL-DERIVED FACTOR-1 PLAYS IMPORTANT ROLES IN THE REGULATION OF HUMAN EARLY B- AND T/NK-LINEAGE LYMPHOID DIFFERENTIATION IN DIFFERENT MANNERS

EHA Library, Hirohito Minami, 99870

COMPARISON OF SELF-RENEWAL EXPRESSION IN STROMAL IN VITRO AND IN VIVO MICROENVIRONMENT MODELS – CRITICAL DIFFERENCES AND THEIR IMPACT ON HEMATOPOIETIC SUPPORT FUNCTIONS

EHA Library, Gillian Horne, 99871

OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%≤ AND >10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT

EHA Library, A. Emre Eskazan, 99872

EXPRESSION OF PD-I LIGANDS FOR CLASSICAL HODGKIN LYMPHOMA PROGNOSIS

EHA Library, Iryna Kriachok, 99873

PATIENT CHARACTERISTICS AND ADVERSE EVENTS (AES) OF TYROSINE KINASE INHIBITORS (TKIS) FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) IN REAL WORLD SETTINGS

EHA Library, Stuart L. Goldberg, 99874

THE EFFECT OF NILOTINIB IN CHRONIC MYELOID LEUKEMIA TREATMENT DOSE ON FERTILITY AND TERATOGENICITY IN A HEALTHY MOUSE MODEL

EHA Library, Guldane Seval, 99875